Sana Biotechnology (SANA)
NASDAQ:SANA
US Market
Holding SANA?
Track your performance easily

Sana Biotechnology (SANA) Financial Statements

265 Followers

Sana Biotechnology Financial Overview

Sana Biotechnology's market cap is currently ―. The company's EPS TTM is $-1.15; its P/E ratio is -3.27; Sana Biotechnology is scheduled to report earnings on November 5, 2024, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -50.29M$ -69.47M$ -74.45M$ -164.25M$ -60.64M
EBITDA$ -44.35M$ -62.38M$ -59.95M-$ -52.75M
Net Income Common Stockholders$ -50.29M$ -107.47M$ -88.12M$ -164.25M$ -114.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 251.64M$ 311.08M$ 205.19M$ 268.57M$ 332.01M
Total Assets$ 618.67M$ 681.38M$ 565.30M$ 631.44M$ 707.15M
Total Debt$ 98.56M$ 106.09M$ 104.10M$ 96.86M$ 113.14M
Net Debt$ -153.09M$ -204.99M$ -101.10M$ -171.71M$ -218.88M
Total Liabilities$ 279.02M$ 306.24M$ 277.79M$ 265.59M$ 352.12M
Stockholders Equity$ 335.51M$ 375.14M$ 287.51M$ 365.85M$ 355.03M
Cash Flow-
Free Cash Flow$ -71.60M$ -81.48M$ -66.00M-$ -54.87M
Operating Cash Flow$ -58.54M$ -65.63M$ -51.96M$ -63.55M$ -53.30M
Investing Cash Flow$ 5.82M$ -77.23M$ 15.31M$ 51.35M$ 37.17M
Financing Cash Flow$ 10.63M$ 186.40M$ 1.72M$ 187.00K$ 29.50M
Currency in USD

Sana Biotechnology Earnings and Revenue History

Sana Biotechnology Debt to Assets

Sana Biotechnology Cash Flow

Sana Biotechnology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis